Københavns Universitetshospital er et samarbejde mellem Det Sundhedsvidenskabelige Fakultet ved Københavns Universitet, hospitalerne i Region Hovedstaden og Region Sjælland samt Steno Diabetes Center, der er associeret medlem.

During the past decade, Rigshospitalet Copenhagen University Hospital conducted 172 clinical trials. In the 10-year time frame, 172 clinical trials started and 38 clinical trials were completed, i.e. on average, 22.1% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 27 clinical trials were completed. i.e. 34.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rigshospitalet Copenhagen University Hospital" #1 sponsor was "Rigshospitalet, Denmark" with 59 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials sponsored, "Celgene" with 9 trials sponsored, "Abbott Medical Devices" with 5 trials sponsored and "Anders Fink-Jensen, MD, DMSci" with 5 trials sponsored. Other sponsors include 185 different institutions and companies that sponsored additional 123 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rigshospitalet Copenhagen University Hospital" #1 collaborator was "Rigshospitalet, Denmark" with 10 trials as a collaborator, "Aarhus University Hospital" with 8 trials as a collaborator, "Aalborg University Hospital" with 6 trials as a collaborator, "Odense University Hospital" with 6 trials as a collaborator and "National Cancer Institute (NCI)" with 5 trials as a collaborator. Other collaborators include 292 different institutions and companies that were collaborators in the rest 226 trials.

According to Clinical.Site data, the most researched conditions in "Rigshospitalet Copenhagen University Hospital" are "Coronary Artery Disease" (12 trials), "Heart Failure" (9 trials), "Ovarian Cancer" (6 trials), "Stroke" (6 trials) and "Aortic Valve Stenosis" (5 trials). Many other conditions were trialed in "Rigshospitalet Copenhagen University Hospital" in a lesser frequency.

Most popular intervention types in "Rigshospitalet Copenhagen University Hospital" are "Drug" (145 trials), "Device" (43 trials), "Procedure" (35 trials), "Other" (33 trials) and "Biological" (22 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Dexamethasone" (6 trials), "cisplatin" (6 trials), "Cyclophosphamide" (5 trials) and "etoposide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Rigshospitalet Copenhagen University Hospital" are 246 trials for "All" genders, 18 trials for "Male" genders and 14 trials for "Female" genders.

Currently, there are 101 active trials in "Rigshospitalet Copenhagen University Hospital". 3 are not yet recruiting, 58 are recruiting, 38 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 133 completed trials in Rigshospitalet Copenhagen University Hospital, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Rigshospitalet Copenhagen University Hospital, 27 "Phase 1" clinical trials were conducted, 72 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 73 trials that are defined as “Not Applicable".